Figure 1 from Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption
Kristin M. Morder(University of Pittsburgh), Abigail E. Overacre-Delgoffe, Drew E. Hurd(UPMC Hillman Cancer Center), Diwakar Davar(University of Pittsburgh), Ansen B.P. Burr(University of Pittsburgh), Zakaria Larbi Dahmani(University of Pittsburgh), Larry Kane(University of Pittsburgh), Stacy G. Wendell(University of Pittsburgh), Drew N. Wilfahrt(University of Pittsburgh), Hector Nieves-Rosado(University of Pittsburgh), Dhivyaa Rajasundaram(University of Pittsburgh), Michael Morikone(University of Pittsburgh), Jishnu Das, Greg M. Delgoffe(University of Pittsburgh), Hong Wang(National University of Singapore), William G. Gunn(University of Pittsburgh), Steven J. Mullett(University of Pittsburgh), Madison Nguyen(UPMC Hillman Cancer Center), Kaitlin Bossong(University of Pittsburgh), Bingxian Xie(UPMC Hillman Cancer Center)
Cited by 0
Related Papers
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
|Nature Immunology|2011|1.1k
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
|Arthritis & Rheumatism|2010|481
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
|The Journal of Experimental Medicine|2018|302
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
|Nature Immunology|2022|245